Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Net sales
Net sales		$ 910.7	$ 1,028.1
Cost of sales
Total cost of sales		683.9	782.0
Gross profit		226.8	246.1
Selling and administrative expense		222.1	230.3
Research, development and engineering expense		32.5	36.9
(Gain) loss on sale of assets, net		(1.8)	3.4
Total operating expense		252.8	270.6
Operating profit (loss)		(26.0)	(24.5)
Other income (expense)
Interest income		1.1	2.9
Interest expense		(48.0)	(50.9)
Foreign exchange gain, net		0.4	2.8
Miscellaneous, net		(0.9)	(1.4)
Loss before taxes		(73.4)	(71.1)
Income tax expense		20.0	60.4
Equity in earnings of unconsolidated subsidiaries		0.0	(0.4)
Net loss		(93.4)	(131.9)
Net (loss) income attributable to noncontrolling interests		(0.6)	0.8
Net loss attributable to Diebold Nixdorf, Incorporated		$ (92.8)	$ (132.7)
Basic and diluted weighted-average shares outstanding	[1]	77.2	76.4
Net loss attributable to Diebold Nixdorf, Incorporated
Basic and diluted loss per share		$ (1.20)	$ (1.74)
Service [Member]
Net sales
Net sales		$ 587.8	$ 628.7
Cost of sales
Total cost of sales		437.5	471.5
Product [Member]
Net sales
Net sales		322.9	399.4
Cost of sales
Total cost of sales		246.4	310.5
Retained Earnings [Member]
Other income (expense)
Net loss attributable to Diebold Nixdorf, Incorporated		$ (92.8)	$ (132.7)

[1] Incremental shares of 3.1 and 1.2 for the three months ended March 31, 2020 and 2019, respectively, would have been included in the weighted-average number of shares used in the computation of diluted earnings (loss) per share because their effects are dilutive, but are excluded due to the Company's net loss.